Article
Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report.
Dermatologic therapy - 1 Apr 2022
Sato Takahiko, Noto Mai, Yamada Masayuki, Kono Michihiro
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
